1. Home
  2. HTBK vs VIR Comparison

HTBK vs VIR Comparison

Compare HTBK & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HTBK

Heritage Commerce Corp

HOLD

Current Price

$11.96

Market Cap

667.4M

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.64

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTBK
VIR
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
667.4M
773.5M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
HTBK
VIR
Price
$11.96
$6.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$11.88
$25.73
AVG Volume (30 Days)
361.3K
1.8M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
4.51%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$187,676,000.00
$16,860,000.00
Revenue This Year
$13.16
N/A
Revenue Next Year
$7.61
$48.05
P/E Ratio
$16.48
N/A
Revenue Growth
10.94
N/A
52 Week Low
$8.09
$4.16
52 Week High
$11.71
$14.45

Technical Indicators

Market Signals
Indicator
HTBK
VIR
Relative Strength Index (RSI) 76.48 60.07
Support Level $11.06 $5.45
Resistance Level $11.48 $7.06
Average True Range (ATR) 0.26 0.47
MACD 0.08 0.07
Stochastic Oscillator 96.53 74.22

Price Performance

Historical Comparison
HTBK
VIR

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: